Skip to main content
Erschienen in: Gastric Cancer 3/2014

01.07.2014 | Original Article

The vessels within epithelial circle (VEC) pattern as visualized by magnifying endoscopy with narrow-band imaging (ME-NBI) is a useful marker for the diagnosis of papillary adenocarcinoma: a case-controlled study

verfasst von: Takao Kanemitsu, Kenshi Yao, Takashi Nagahama, Shoko Fujiwara, Yasuhiro Takaki, Yoichiro Ono, Yu Matsushima, Toshiyuki Matsui, Hiroshi Tanabe, Atsuko Ota, Akinori Iwashita

Erschienen in: Gastric Cancer | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

Pathological studies indicate papillary adenocarcinomas are more aggressive than tubular adenocarcinomas, but a definitive diagnosis is difficult using conventional endoscopy alone. The vessels within an epithelial circle (VEC) pattern, visualized using magnifying endoscopy with narrow-band imaging (ME-NBI), may be a feature of papillary adenocarcinoma. The aims of our study were to investigate whether the VEC pattern is useful in the preoperative diagnosis of papillary adenocarcinoma and to determine whether VEC-positive adenocarcinomas are more malignant than VEC-negative lesions.

Patients and materials

From 395 consecutive early gastric cancers resected using the endoscopic submucosal dissection method, we analyzed 35 VEC-positive lesions and 70 VEC-negative control lesions matched for size and macroscopic type. We evaluated (1) the correlation between the incidence of VEC-positive cancers and the histological papillary structure and (2) differences in the incidence of coexisting undifferentiated carcinoma in VEC-positive and VEC-negative cancers and the incidence of submucosal and vascular invasion.

Results

Histological papillary structure was seen in 94 % (33/35) of VEC-positive and 9 % (6/70) of VEC-negative cancers, a significant difference (P < 0.001). The incidence of coexisting undifferentiated carcinoma was 23 % (8/35) in VEC-positive and 3 % (2/70) in VEC-negative cancers (P = 0.002). The incidence of submucosal invasion by the carcinoma was 26 % (9/35) in VEC-positive cancers and 10 % (7/70) in VEC-negative cancers (P = 0.045).

Conclusions

The VEC pattern as visualized using ME-NBI is a promising preoperative diagnostic marker of papillary adenocarcinoma. Coexisting undifferentiated carcinoma and submucosal invasion were each seen in approximately one fourth of VEC-positive cancers.
Literatur
1.
Zurück zum Zitat Lauwers GY, Carnerio F, Graham DY, et al. Tumours of the stomach. In: Bosman FT, Carnerio F, Hruban RH, editors. WHO classification of tumors of the digestive system. Lyon: IARC; 2010. p. 46–80. Lauwers GY, Carnerio F, Graham DY, et al. Tumours of the stomach. In: Bosman FT, Carnerio F, Hruban RH, editors. WHO classification of tumors of the digestive system. Lyon: IARC; 2010. p. 46–80.
2.
Zurück zum Zitat Kaibara N, Kimura O, Nishidoi H, et al. High incidence of liver metastases in gastric cancer with medullary growth pattern. J Surg Oncol. 1985;28:195–8.PubMedCrossRef Kaibara N, Kimura O, Nishidoi H, et al. High incidence of liver metastases in gastric cancer with medullary growth pattern. J Surg Oncol. 1985;28:195–8.PubMedCrossRef
3.
Zurück zum Zitat Mita T, Shimoda T. Risk factors for lymph node metastasis of submucosal invasive differentiated type gastric carcinoma: clinical significance of histological heterogeneity. J Gastroenterol. 2001;36:661–8.PubMedCrossRef Mita T, Shimoda T. Risk factors for lymph node metastasis of submucosal invasive differentiated type gastric carcinoma: clinical significance of histological heterogeneity. J Gastroenterol. 2001;36:661–8.PubMedCrossRef
4.
Zurück zum Zitat Yasuda K, Adachi Y, Shiraishi N, et al. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3:33–8.PubMedCrossRef Yasuda K, Adachi Y, Shiraishi N, et al. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3:33–8.PubMedCrossRef
5.
Zurück zum Zitat Hirota T, Ochiai A, Itabashi M, et al. Significance of histopathological type of gastric carcinoma as a prognostic factor [in Japanese with English abstract]. Stomach Intest. 1991;26:1149–58. Hirota T, Ochiai A, Itabashi M, et al. Significance of histopathological type of gastric carcinoma as a prognostic factor [in Japanese with English abstract]. Stomach Intest. 1991;26:1149–58.
6.
Zurück zum Zitat Uefuji K, Ichikura T, Tamakuma S. Clinical and prognostic characteristics of papillary clear cell carcinoma of stomach. Jpn J Surg. 1996;26:15–163. Uefuji K, Ichikura T, Tamakuma S. Clinical and prognostic characteristics of papillary clear cell carcinoma of stomach. Jpn J Surg. 1996;26:15–163.
7.
Zurück zum Zitat Ito E, Takizawa T. Differentiated adenocarcinoma of the gastric and intestinal phenotype: histological appearance and biological behavior [in Japanese with English abstract]. Stomach Intest. 2003;38:701–6. Ito E, Takizawa T. Differentiated adenocarcinoma of the gastric and intestinal phenotype: histological appearance and biological behavior [in Japanese with English abstract]. Stomach Intest. 2003;38:701–6.
8.
Zurück zum Zitat Ito T, Takizawa T, Horiguchi S, et al. Gastric adenocarcinoma with submucosal invasion: histological appearance and biological behavior [in Japanese with English abstract]. Stomach Intest. 2007;42:7–13. Ito T, Takizawa T, Horiguchi S, et al. Gastric adenocarcinoma with submucosal invasion: histological appearance and biological behavior [in Japanese with English abstract]. Stomach Intest. 2007;42:7–13.
9.
Zurück zum Zitat Koseki K, Takizawa T, Koike M, et al. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer (Phila). 2000;89:724–32.CrossRef Koseki K, Takizawa T, Koike M, et al. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer (Phila). 2000;89:724–32.CrossRef
10.
Zurück zum Zitat Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41:462–7.PubMedCrossRef Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41:462–7.PubMedCrossRef
11.
Zurück zum Zitat Yao K, Iwashita A, et al. White opaque substance within superficial elevated gastric neoplasia as visualized by magnification endoscopy with narrow-band imaging: a new optical sign for differentiating between adenoma and carcinoma. Gastrointest Endosc. 2008;68:574–9.PubMedCrossRef Yao K, Iwashita A, et al. White opaque substance within superficial elevated gastric neoplasia as visualized by magnification endoscopy with narrow-band imaging: a new optical sign for differentiating between adenoma and carcinoma. Gastrointest Endosc. 2008;68:574–9.PubMedCrossRef
12.
Zurück zum Zitat Nagahama T, Yao K, Maki S, et al. Usefulness of magnifying endoscopy with narrow-band imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy (with video). Gastrointest Endosc. 2011;74:1259–67.PubMedCrossRef Nagahama T, Yao K, Maki S, et al. Usefulness of magnifying endoscopy with narrow-band imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy (with video). Gastrointest Endosc. 2011;74:1259–67.PubMedCrossRef
13.
Zurück zum Zitat Ezoe Y, Muto M, Uedo N, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141:2017–25.PubMedCrossRef Ezoe Y, Muto M, Uedo N, et al. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology. 2011;141:2017–25.PubMedCrossRef
14.
Zurück zum Zitat Maki S, Yao K, Nagahama T, et al. Magnifying endoscopy with narrow-band imaging is useful in the differential diagnosis between low-grade adenoma and early cancer of superficial elevated gastric lesions. Gastric Cancer. 2013;16:140–6.PubMedCrossRef Maki S, Yao K, Nagahama T, et al. Magnifying endoscopy with narrow-band imaging is useful in the differential diagnosis between low-grade adenoma and early cancer of superficial elevated gastric lesions. Gastric Cancer. 2013;16:140–6.PubMedCrossRef
15.
Zurück zum Zitat Yao K. VS classification for the diagnosis of early gastric cancer (in Japanese). In: Yao K, editor. Magnifying endoscopy in the stomach. Tokyo: Nihon Medical Center; 2009. p. 107–81. Yao K. VS classification for the diagnosis of early gastric cancer (in Japanese). In: Yao K, editor. Magnifying endoscopy in the stomach. Tokyo: Nihon Medical Center; 2009. p. 107–81.
16.
Zurück zum Zitat Uedo N. Early gastric cancer (differentiated type): 0-IIc (in Japanese). In: Muto M, Yao K, Sano Y, editors. The atlas of endoscopy with narrow band imaging. Tokyo: Nankodo; 2011. p. 166–7. Uedo N. Early gastric cancer (differentiated type): 0-IIc (in Japanese). In: Muto M, Yao K, Sano Y, editors. The atlas of endoscopy with narrow band imaging. Tokyo: Nankodo; 2011. p. 166–7.
17.
Zurück zum Zitat Otsuji E, Ichikawa D, Ochiai T, et al. Prediction of lymph node metastasis by size of early gastric carcinoma. Hepatogastroenterology. 2007;54:602–5.PubMed Otsuji E, Ichikawa D, Ochiai T, et al. Prediction of lymph node metastasis by size of early gastric carcinoma. Hepatogastroenterology. 2007;54:602–5.PubMed
18.
Zurück zum Zitat Yao K, Nagahama T, Matsui T, et al. Detection and characterization of early gastric cancer for curative endoscopic submucosal dissection. Dig Endosc. 2013;25(suppl 1):44–54.PubMedCrossRef Yao K, Nagahama T, Matsui T, et al. Detection and characterization of early gastric cancer for curative endoscopic submucosal dissection. Dig Endosc. 2013;25(suppl 1):44–54.PubMedCrossRef
Metadaten
Titel
The vessels within epithelial circle (VEC) pattern as visualized by magnifying endoscopy with narrow-band imaging (ME-NBI) is a useful marker for the diagnosis of papillary adenocarcinoma: a case-controlled study
verfasst von
Takao Kanemitsu
Kenshi Yao
Takashi Nagahama
Shoko Fujiwara
Yasuhiro Takaki
Yoichiro Ono
Yu Matsushima
Toshiyuki Matsui
Hiroshi Tanabe
Atsuko Ota
Akinori Iwashita
Publikationsdatum
01.07.2014
Verlag
Springer Japan
Erschienen in
Gastric Cancer / Ausgabe 3/2014
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-013-0295-1

Weitere Artikel der Ausgabe 3/2014

Gastric Cancer 3/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.